Upregulated terminal differentiation-induced non-coding RNA (TINCR) is associated with poor survival in NSCLC patients, Zhu et al. pointed out that TINCR could target BRAF and mediate downstream MAPK pathway to promote NSCLC tumorigenesis (72). This evidence concerns the gene BRAF and non-small cell lung carcinoma.